Component portfolio and prices

Portfolio 

Portfolio of blood components and guidance (PDF 1689KB)

This provides details of therapeutic blood components supplied to hospitals, including constituents, and information on:

  • specifications
  • identification barcodes
  • quality standards and monitoring
  • storage and handling
  • clinical indications and contraindications
  • specialist requirements
  • dosage, administration, recognition of adverse effects
  • material safety data sheet

Prices

Availability of non stock and special components

 

UK sourced FFP and cryoprecipitate components for neonates and infants 

Since August 2020 these components have been manufactured to a revised specification to improve their quality for transfusion. This specification will be added to the component portfolio when it is next revised.